Dias Marlon Lemos, Paranhos Bruno Andrade, Goldenberg Regina Coeli Dos Santos
Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.
Instituto Nacional de Ciência e Tecnologia em Medicina Regenerativa - INCT - REGENERA, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.
J Tissue Eng. 2022 Jun 20;13:20417314221105305. doi: 10.1177/20417314221105305. eCollection 2022 Jan-Dec.
Liver transplantation is the only definitive treatment for many diseases that affect this organ, however, its quantity and viability are reduced. The study of liver scaffolds based on an extracellular matrix is a tissue bioengineering strategy with great application in regenerative medicine. Collectively, recent studies suggest that liver scaffold transplantation may assist in reestablishing hepatic function in preclinical diseased animals, which represents a great potential for application as a treatment for patients with liver disease in the future. This review focuses on useful strategies to promote liver scaffold transplantation and the main open questions about this context. We outline the current knowledge about ex vivo bioengineered liver transplantation, including the surgical techniques, recipient survival time, scaffold preparation before transplantation, and liver disease models. We also highlight the current limitations and future directions regarding in vivo bioengineering techniques.
肝移植是治疗许多影响该器官疾病的唯一确定性疗法,然而,其数量和活力正在减少。基于细胞外基质的肝支架研究是一种在再生医学中具有广泛应用的组织生物工程策略。总体而言,最近的研究表明,肝支架移植可能有助于在临床前患病动物中重建肝功能,这代表了未来作为肝病患者治疗方法应用的巨大潜力。本综述重点关注促进肝支架移植的有用策略以及关于这一背景的主要未解决问题。我们概述了关于体外生物工程肝移植的当前知识,包括手术技术、受体存活时间、移植前的支架制备以及肝病模型。我们还强调了体内生物工程技术的当前局限性和未来方向。